Bristol-Myers joins forces with digital therapeutics co; Wearable cardioverter defibrillator scores $145M+ in Series C haul
→ Bristol-Myers Squibb has signed on digital therapeutics player Voluntis to develop a mobile app that will give cancer patients …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
